Apolipoprotein Specificity for Lipid Efflux by the Human ABCAI Transporter

Biochemical and Biophysical Research Communications - Tập 280 - Trang 818-823 - 2001
Alan T. Remaley1, John A. Stonik1, Steven J. Demosky1, Edward B. Neufeld1, Alexander V. Bocharov2, Tatyana G. Vishnyakova1, Thomas L. Eggerman2, Amy P. Patterson1, Nicholas J. Duverger3, Silvia Santamarina-Fojo1, H.Bryan Brewer1
1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
2Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland
3Aventis-Pharma, Department of Genomics, Every, France

Tài liệu tham khảo

Hoeg, 1994, Reverse cholesterol transport, 351 Johnson, 1991, Biochim. Biophys. Acta Lipids Lipid Metabol., 1085, 273, 10.1016/0005-2760(91)90132-2 Oram, 1996, Apolipoprotein-mediated removal of cellular cholesterol and phospholipids, J. Lipid Res., 37, 2473, 10.1016/S0022-2275(20)37453-8 Mendez, 1997, Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion, J. Lipid Res., 38, 1807, 10.1016/S0022-2275(20)37155-8 Assmann, 1995, Familial high density lipoprotein deficiency: Tangier disease, 2053 Francis, 1995, Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-1 in Tangier disease, J. Clin. Invest., 96, 78, 10.1172/JCI118082 Remaley, 1997, Arterioscler. Thromb. Vasc. Biol., 17, 1813, 10.1161/01.ATV.17.9.1813 Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat. Genet., 22, 352, 10.1038/11921 Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat. Genet., 22, 347, 10.1038/11914 Brooks-Wilson, 1999, Mutations in ABC1 in tangier disease and familial high-density lipoprotein deficiency, Nat. Genet., 22, 336, 10.1038/11905 Remaley, A. T., Rosier, M., Knapper, C., Peterson, K. M., Koch, C., Dinger, M., Duverger, N., Assman, G., Dean, M., Santamarina-Fojo, S., Fredrickson, D. S., Denefle, P., and Brewer, H. B. Jr.Human ATP binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original tangier disease kindred. Proc. Natl. Acad. Sci. USA96, 12685–12690. Lawn, 1999, The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway, J. Clin. Invest., 104, R25, 10.1172/JCI8119 Klein, 1999, An inventory of the human ABC proteins, Biochim. Biophys. Acta, 1461, 237, 10.1016/S0005-2736(99)00161-3 Wang, 2000, Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1, J. Biol. Chem., 275, 33053, 10.1074/jbc.M005438200 Hamon, 2000, ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine, Nat. Cell Biol., 2, 399, 10.1038/35017029 Segrest, 1992, The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function, J. Lipid Res., 33, 141, 10.1016/S0022-2275(20)41536-6 Santamarina-Foho, 2000, Complete genomic sequence of the human ABCA1 gene: Functional analysis of the ABCA1 promoter, Proc. Natl. Acad. Sci. USA, 97, 7987, 10.1073/pnas.97.14.7987 Schumaker, 1986, Sequential flotation ultracentrifugation, 155, 10.1016/0076-6879(86)28066-0 Brewer, 1986, Isolation and characterization of apolipoproteins A-I, A-II, and A-IV, 223, 10.1016/0076-6879(86)28070-2 Rall, 1986, Isolation and characterization of apolipoprotein E, 273, 10.1016/0076-6879(86)28073-8 Jackson, 1986, Isolation and properties of apolipoproteins C-I, C-II, and C-III, 223 Sinn, 1988, Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent, Anal. Biochem., 170, 186, 10.1016/0003-2697(88)90107-8 Azstalos, 1995, Presence and formation of free apolipoprotein A-I-like particles in human plasma, Art. Thromb. Vasc. Biol., 15, 1419, 10.1161/01.ATV.15.9.1419 Hara, 1992, Alpha-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux, Lipids, 27, 302, 10.1007/BF02536480 Mendez, 1994, Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol, J. Clin. Invest., 94, 1698, 10.1172/JCI117515 Lin, 1999, Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E, J. Lipid Res., 40, 1618, 10.1016/S0022-2275(20)33407-6 Weinberg, 1985, Structural properties and lipid binding of human apolipoprotein A-IV, J. Biol. Chem., 260, 4914, 10.1016/S0021-9258(18)89159-1 Langmann, 1999, Biochem. Biophys. Res. Commun., 257, 29, 10.1006/bbrc.1999.0406 Takahashi, 2000, Identification of cAMP analogue inducible genes in RAW264 macrophages, Biochim. Biophys. Acta, 1492, 385, 10.1016/S0167-4781(00)00133-0 Williams, 2000, Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif, J. Biol. Chem., 275, 18897, 10.1074/jbc.M002411200